Work

Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i)

Year: 2015

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2015.pa2110

Authors: Marius Hoeper, Raymond Benza, Gerald Simonneau, James Klinger, David Langleben, Robert Naeije, Paul Corris

Institutions: Medizinische Hochschule Hannover, Allegheny General Hospital, Université Paris-Sud, Bicêtre Hospital, Rhode Island Hospital, Jewish General Hospital, Lady Davis Institute for Medical Research, Erasmus Hospital, Freeman Hospital

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2561592087

Cites:

Cited by: 4

Related to: 10